1[1]Bousquet J,Lockey R,van Cauwenberge P,et al.Allergen Immunotherapy:Therapeutic vaccines for allergic diseases.A WHO position paper[J].Allergy Clin Immunol,198,102:558-562.
2[2]WHO Position Paper Allergen immunotherapy therapeutic vaccines for allergic disease[J].European Journal of Allergy and Clinical Immunology Allergy,1998,53(Supp144):1.
4[4]Muller U,Akdis CA,Fricker M,et al.Successful immunotherapy with T cell epitope peptides of bee venom phospholipase A2 induces specific T cell anergy in bee sting allergic patients[J].Allergy Clin Immunol,1998,101:747-754.
5[5]Whslen RG,Waiwar R,Soong NW.DNA shuffling and vaccine[J].Curr Opin Mol Ther,2001,3(1):31.
6[6]Maguire P,Nicodemus C,Robinson D,et al.The safety and efficacy of ALLERVAX CAT in cat allergic patients[J].Clin Immunol,1999,93:222-231.
7[7]Kowalczyk DW,Ertl CJ.Immune responses to DNA vaccines[J].Cell Mol Life Sci,1999,55,751-770.
8[8]Rudolf Valenta,Dietrich Kraft.From allergen structure to new forms of allergen-specific immunotherapy[J].Current Opinion in Immunology,2002,14:718-727.
9[9]Niederberger V,Stubner P,Spitzauer S,et al.Skin test results but not serology reflect immediate type respiratory sensitivity:a study performed with recombinant allergens molecules[J].J Invest Dermatol,2001,117:848-851.
10[10]Nikolaizik WH,Weichel M,Blaser K,et al.Intracutaneous test with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy[J].Am J Respir Crit Care Med,2002,165:916-921.
